GDEV Inc. (NASDAQ:GDEV) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

GDEV Inc. (NASDAQ:GDEV) shares have had a horrible month, losing 25% after a relatively good period beforehand. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 11% in that time.

In spite of the heavy fall in price, you could still be forgiven for feeling indifferent about GDEV's P/S ratio of 1.1x, since the median price-to-sales (or "P/S") ratio for the Entertainment industry in the United States is also close to 1.3x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.

See our latest analysis for GDEV

ps-multiple-vs-industry
NasdaqGM:GDEV Price to Sales Ratio vs Industry November 19th 2024
Advertisement

What Does GDEV's P/S Mean For Shareholders?

GDEV hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. Perhaps the market is expecting its poor revenue performance to improve, keeping the P/S from dropping. If not, then existing shareholders may be a little nervous about the viability of the share price.

Keen to find out how analysts think GDEV's future stacks up against the industry? In that case, our free report is a great place to start.

Is There Some Revenue Growth Forecasted For GDEV?

The only time you'd be comfortable seeing a P/S like GDEV's is when the company's growth is tracking the industry closely.

In reviewing the last year of financials, we were disheartened to see the company's revenues fell to the tune of 3.9%. However, a few very strong years before that means that it was still able to grow revenue by an impressive 32% in total over the last three years. Although it's been a bumpy ride, it's still fair to say the revenue growth recently has been more than adequate for the company.

Shifting to the future, estimates from the dual analysts covering the company suggest revenue growth is heading into negative territory, declining 0.05% over the next year. With the industry predicted to deliver 12% growth, that's a disappointing outcome.

With this information, we find it concerning that GDEV is trading at a fairly similar P/S compared to the industry. Apparently many investors in the company reject the analyst cohort's pessimism and aren't willing to let go of their stock right now. There's a good chance these shareholders are setting themselves up for future disappointment if the P/S falls to levels more in line with the negative growth outlook.

What Does GDEV's P/S Mean For Investors?

GDEV's plummeting stock price has brought its P/S back to a similar region as the rest of the industry. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.

It appears that GDEV currently trades on a higher than expected P/S for a company whose revenues are forecast to decline. When we see a gloomy outlook like this, our immediate thoughts are that the share price is at risk of declining, negatively impacting P/S. If the declining revenues were to materialize in the form of a declining share price, shareholders will be feeling the pinch.

You always need to take note of risks, for example - GDEV has 3 warning signs we think you should be aware of.

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGM:GDEV

GDEV

Develops and publishes online games in the United States, Europe, Asia, and internationally.

Undervalued with solid track record.

Advertisement

Weekly Picks

DA
davidlsander
OPTH logo
davidlsander on Optimi Health ·

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Fair Value:US$1259.6% undervalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0328.6% undervalued
36 users have followed this narrative
3 users have commented on this narrative
12 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.524.7% undervalued
22 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.719.3% undervalued
47 users have followed this narrative
3 users have commented on this narrative
20 users have liked this narrative

Updated Narratives

PE
RYTM logo
peter_4mgsy on Rhythm Pharmaceuticals ·

High-Growth Emerging Commercial Stage Biotech

Fair Value:US$13413.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
woodworthfund
RAIL logo
woodworthfund on FreightCar America ·

ALL ABOARD THE VALUE TRAIN: WHY $RAIL MIGHT BE HEADED NORTH - FREIGHTCAR AMERICA - Long term price target of $25

Fair Value:US$2568.4% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
268A logo
AstrisCorporateAdvisory on Rigaku Holdings ·

Capitalizing on rising semiconductor complexity

Fair Value:JP¥2.52k22.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
288 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.5% overvalued
153 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0941.5% undervalued
173 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative